Sca7 clinical trials

Explore recruiting sca7 clinical trials.

Recruiting sca7 studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sca7 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Riluzole (Glentek) in patients with SpinoCerebellar Ataxia type 7: a randomized, doubleblind, placebo-controlled pilot trial with a lead in phase

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Sca7 trials by city

Sca7 in Toronto Sca7 in Vancouver Sca7 in Montreal Sca7 in Calgary Sca7 in Edmonton Sca7 in Ottawa Sca7 in Winnipeg Sca7 in Quebec City Sca7 in Hamilton Sca7 in Kitchener Sca7 in London Sca7 in Halifax Sca7 in New York Sca7 in Los Angeles Sca7 in Chicago Sca7 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease